Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated. (2016)

First Author: Royston P
Attributed to:  Design of Trials, Meta-analyses and observational studies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12874-016-0110-x

PubMed Identifier: 26869168

Publication URI: http://europepmc.org/abstract/MED/26869168

Type: Journal Article/Review

Volume: 16

Parent Publication: BMC medical research methodology

ISSN: 1471-2288